Am J Transplant, Volume 22, Suppl 3 Archives - Page 80 of 190 - ATC Abstracts

2022 American Transplant Congress
Factors Linked with Evaluation to Wait Listing for Referred Patients at the University of Texas Medical Branch’s Main Center and Outreach Clinic – A Step Towards Kidney Transplantation
A. Rizvi¹, M. Mujtaba², S. Hussain³, J. Fair⁴, M. Kueht⁴, A. Gamilla-Crudo⁵
¹Internal Medicine, Nephrology, University of Texas Medical Branch, Galveston, TX, ²University of Texas Medical Branch, Galveston, TX, ³University of Texas Medical Branch, Houston, TX, ⁴Surgery, University of Texas Medical Branch, Galveston, TX, ⁵University of Texas Medical Branch, League City, TX
*Purpose: Numerous factors can be associated with transplant candidates’ placement on the wait list. We herein set forth to assess patient characteristics and factors associated…
2022 American Transplant Congress
High Dimensional Analysis of IL-10-Producing Human B Cells and Their Characterization in Operationally Tolerant Transplant Recipients
M. C. Glass, D. Glass, J. Oliveria, B. Mbiribindi, C. Esquivel, S. M. Krams, S. C. Bendall, O. M. Martinez
Stanford University Sch of Med, Stanford, CA
*Purpose: Regulatory B cells (Breg) participate in control of alloimmune responses in murine models of graft tolerance and are associated with improved outcomes in clinical…
2022 American Transplant Congress
Post-Kidney Transplant Dementia Risk by Modifiable Risk Factors and CNIs Among Older Recipients
Y. Chen¹, J. Ahn¹, N. Chu¹, S. Bae¹, M. A. Schnitzler², G. Hess³, K. Lentine⁴, D. Segev⁵, M. McAdams-DeMarco¹
¹Johns Hopkins School of Medicine, Baltimore, MD, ²Surgery, Saint Louis University, O Fallon, IL, ³Drexel University School of Medicine, Philadelphia, PA, ⁴Saint Louis University, St. Louis, MO, ⁵Johns Hopkins University, Baltimore, MD
*Purpose: Up to 17% of older recipients develop dementia after kidney transplant (KT). While there are known modifiable risk factors for dementia among community-dwelling older…
2022 American Transplant Congress
CD209+ Macrophages-Mediated Immunosuppressive Effects in ADPKD Tissues
Z. Ou¹, Y. Wang¹, Z. Yan¹, Y. Liu¹, Q. Li¹, Y. Fang¹, J. Geng¹, W. Deng¹, Z. Li¹, R. Xia¹, W. Zeng¹, J. Xu¹, C. Wu², Y. Miao¹
¹Nanfang Hospital, Guangzhou, China, ²Departments of Urology and Pathology, Massachusetts General Hospital, Boston, MA
*Purpose: The intensity of maintenance immunosuppression required in autosomal dominant polycystic kidney disease (ADPKD) patients after renal transplantation is lower than average, suggesting a reduced…
2022 American Transplant Congress
Significant Improvements, but Consistent Disparities in Survival for African Americans After Liver Transplantation
S. S. Keeling
Baylor College of Medicine, Houston, TX
*Purpose: Despite improvements in survival for all races in the past twenty years, African American patients have worse liver transplant outcomes after undergoing orthotopic liver…
2022 American Transplant Congress
Trends in Donor Cause of Death and the Effect on Outcomes in Liver Transplantation Over 15-Years
J. A. Steggerda¹, I. K. Kim², D. P. Ladner¹, J. Caicedo¹, D. Borja-Cacho¹
¹Transplant Surgery, Northwestern Memorial Hospital, Chicago, IL, ²Transplant Surgery, Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Over the past 15 years, there has been a significant shift in donor cause of death (COD), which has coincided with an increase in…
2022 American Transplant Congress
A Novel Method for Ex Vivo Stimulation of Mesenchymal Stem Cells via Invariant Natural Killer T Cell Activation with ɑ-galactosylceramide
R. Ishii¹, E. Kawaguchi¹, T. Yamakawa¹, H. Ishigooka¹, T. Ikeda¹, R. Ishiyama¹, K. Saiga¹, T. Takagi¹, Y. Ishii², K. Tanabe¹
¹Tokyo Women's Medical University, Tokyo, Japan, ²Department of Immunological Diagnosis, Juntendo University Graduate School of Medicine, Tokyo, Japan
*Purpose: Mesenchymal stem cells (MSCs) typically exhibit unique regenerative and immunomodulatory properties when exposed to proinflammatory cytokines. Invariant natural killer T (iNKT) cells are known…
2022 American Transplant Congress
Characterization Of Gzmb+ Bregs Using Single Cell Rnaseq
N. Sailliet, H. Le Mai, A. Dupuy, C. Fourgeux, M. Chesneau, J. Poschmann, R. Danger, S. Brouard
CRT2I INSERM UMR1064, Nantes, France
*Purpose: Granzyme B (GZMB)+ B cells are increased in blood from transplanted patients who tolerate a kidney graft without immunosuppressive treatment. We demonstrated that these…
2022 American Transplant Congress
Kidney Nonprocurement in Deceased Donors with Acute Kidney Injury
K. Yu¹, K. King¹, S. Husain¹, J. Stevens¹, C. Parikh², S. Mohan¹
¹Division of Nephrology, Columbia University Medical Center, New York, NY, ²Division of Nephrology, Johns Hopkins School of Medicine, Baltimore, MD
*Purpose: Deceased donor acute kidney injury (AKI) is associated with high rates of kidney discard by transplant centers, despite evidence of excellent post-transplant outcomes. High…
2022 American Transplant Congress
Influence of Converting Kidney Transplant Recipients with High Tacrolimus Variability to the Once Daily LCP Tac Formulation
D. Taber, F. Bartlett, N. Patel, T. Sprague, S. Patel, J. Newman, E. Andrade, N. Rao, A. Posadas, V. Rao, M. Casey, D. Dubay, V. Rohan
Med Univ of South Carolina, Charleston, SC
*Purpose: Tacrolimus (Tac) is the cornerstone of immunosuppression used in kidney transplant recipients (KTRs). Tac high variability, low time in therapeutic range and non-adherence are…